Pemtumomab

From WikiMD.org
Jump to navigation Jump to search

Pemtumomab

Pemtumomab (pronunciation: pem-tu-mo-mab) is a monoclonal antibody used in the treatment of certain types of cancer. It is a type of radioimmunotherapy and is sometimes referred to as a radiolabeled antibody.

Etymology

The name "Pemtumomab" is derived from parts of the phrases "PErsonalized Medicine", "TUMOr", and "MAB" (an abbreviation for monoclonal antibody).

Usage

Pemtumomab is used in the treatment of certain types of cancer, including ovarian cancer and peritoneal cancer. It works by binding to a specific protein found on the surface of cancer cells, allowing a radioactive substance to be delivered directly to the cancer cells.

Related Terms

  • Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
  • Radioimmunotherapy: A type of therapy that uses radioactive substances in combination with antibodies to treat cancer.
  • Radiolabeled antibody: An antibody that has been joined with a radioactive substance, used to detect or treat cancer.
  • Ovarian cancer: A type of cancer that begins in the ovaries.
  • Peritoneal cancer: A rare cancer that develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus and extends over the bladder and rectum.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski